AMOXICILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Amoxicillin patents expire, and what generic alternatives are available?
Amoxicillin is a drug marketed by Aurobindo, Chartwell, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma Intl, Sun Pharm Inds Ltd, Teva, Aurobindo Pharma Ltd, Chartwell Rx, Hikma, Ph Health, Apothecon, Aurobindo Pharma, Cipla, Deva Holding As, Micro Labs Ltd India, Sandoz Inc, Apotex Inc, and Teva Pharms Usa. and is included in eighty-five NDAs.
The generic ingredient in AMOXICILLIN is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxicillin
A generic version of AMOXICILLIN was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for AMOXICILLIN?
- What are the global sales for AMOXICILLIN?
- What is Average Wholesale Price for AMOXICILLIN?
Summary for AMOXICILLIN
| US Patents: | 0 |
| Applicants: | 22 |
| NDAs: | 85 |
| Finished Product Suppliers / Packagers: | 37 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 680 |
| Patent Applications: | 4,658 |
| Drug Prices: | Drug price information for AMOXICILLIN |
| Drug Sales Revenues: | Drug sales revenues for AMOXICILLIN |
| What excipients (inactive ingredients) are in AMOXICILLIN? | AMOXICILLIN excipients list |
| DailyMed Link: | AMOXICILLIN at DailyMed |
Recent Clinical Trials for AMOXICILLIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Agnaldo Rocha de Souza Junior | NA |
| Qilu Hospital of Shandong University | NA |
| Shandong University of Traditional Chinese Medicine | NA |
Pharmacology for AMOXICILLIN
| Drug Class | Penicillin-class Antibacterial |
